FDA approves soft tissue matrix

[Guest guest]

FDA OK's CryoLife's tissue repair matrixATLANTA, Dec. 11 (UPI) -- CryoLife said Monday the U.S. Food and Drug Administration approved ProPatch, a matrix used to reinforce weakened soft tissues.ProPatch, developed from bovine pericardial tissue, can be used for a variety of soft tissue repair indications, a $600 million market."ProPatch provides an effective alternative to the products available for soft tissue repair," said , CryoLife's president and chief executive officer. "The indications for its use are broad and varied, particularly for hernia repairs in which the use of a natural tissue product, such as ProPatch, is preferred."Other indications include chest wall repair, muscle flap reinforcement, rectal and vaginal prolapse and reconstructive procedures. ProPatch can also be used for reinforcement of the rotator cuff and various tendons, including patellar, Achilles, biceps and quadriceps.http://www.upi.com/HealthBusiness/view.php?StoryID=20061211-091930-3110r Sears, DCNW PDX